Press Release: Roche and InterMune Reach Definitive Merger Agreement

Press Release: Roche and InterMune Reach Definitive Merger Agreement Roche and InterMune Reach Definitive Merger Agreement — Roche to acquire InterMune for $74.00 per share — — InterMune’s lead product pirfenidone for idiopathic pulmonary fibrosis to expand…

Read more…

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s